On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services ...
On Friday, the Centers for Medicare & Medicaid Services (CMS) released the second list of prescription medications covered under Medicare Part D. The list has 15 ... of Health and Human Services ...
The Centers for Medicare and Medicaid Services (CMS) on Friday announced 15 additional Medicare Part D drugs selected for the next round of pricing negotiations, including Novo Nordisk’s (NVO) popular ...
The Centers for Medicare & Medicaid Services wants to lower the cost for 15 more drugs including Ozempic and Wegovy.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Medicare will continue to negotiate drug prices in 2025. (HealthDay News) — Medicare will soon negotiate prices for 15 more drugs as part of an ... lower costs,” Xavier Becerra, HHS secretary ...
The 15 drugs selected by HHS are all covered under Medicare Part D and represent the second ... Health and Human Services Secretary Xavier Becerra said in the department's statement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback